Investigational Site Number : 2030003

Jihlava 58633

0 studies enrolling now · 2 studies all time

What they study most

Relapsing Multiple Sclerosis

Studies at this site

• Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis — Completed
• Dose-finding Study for SAR442168 in Relapsing Multiple Sclerosis — Completed